Editorial
Published on 05 Jan 2024
Editorial: Epstein-Barr Virus and multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1330181
- 2,039 views
Type at least 3 characters
1,369 articles
Editorial
Published on 19 Dec 2023
Editorial: Innovative OMICs-technology applications to reach a diagnosis and bring new therapies to immune-mediated neurological diseases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1348986
- 803 views
- 1 citation
Brief Research Report
Published on 19 Dec 2023
Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1327947
- 3,429 views
- 7 citations
Original Research
Published on 13 Dec 2023
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing–remitting multiple sclerosis patients
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1234869
- 3,138 views
- 5 citations
Original Research
Published on 12 Dec 2023
Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1213532
- 3,160 views
- 7 citations
Case Report
Published on 08 Dec 2023
Case Report: Anti-mGluR5 antibody-negative Ophelia syndrome with failed lymph node biopsy due to steroid therapy
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1188154
- 1,928 views
Correction
Published on 08 Dec 2023
Corrigendum: Treatment of surgical brain injury by immune tolerance induced by peripheral intravenous injection of biotargeting nanoparticles loaded with brain antigens
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1335541
- 685 views
Original Research
Published on 05 Dec 2023
Biological analysis of the potential pathogenic mechanisms of Infectious COVID-19 and Guillain-Barré syndrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1290578
- 2,596 views
- 3 citations
Original Research
Published on 04 Dec 2023
Causal relationships between susceptibility and severity of COVID-19 and neuromyelitis optica spectrum disorder (NMOSD) in European population: a bidirectional Mendelian randomized study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1305650
- 3,433 views
- 6 citations
Case Report
Published on 01 Dec 2023
Case Report: Extraocular muscles paralysis associated with GAD65 antibody: a case series study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1256089
- 2,152 views
Review
Published on 30 Nov 2023
The role of midkine in health and disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1310094
- 7,795 views
- 11 citations
Review
Published on 29 Nov 2023
Bioavailable central nervous system disease-modifying therapies for multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1290666
- 8,034 views
- 4 citations
Original Research
Published on 28 Nov 2023
Association of retinal vessel pathology and brain atrophy in relapsing-remitting multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1284986
- 2,895 views
- 6 citations
Original Research
Published on 23 Nov 2023
The transcriptomics profiling of blood CD4 and CD8 T-cells in narcolepsy type I
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1249405
- 4,376 views
- 5 citations
Original Research
Published on 22 Nov 2023
Limitations of PLX3397 as a microglial investigational tool: peripheral and off-target effects dictate the response to inflammation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1283711
- 7,205 views
- 11 citations
Original Research
Published on 16 Nov 2023
Cerebrospinal fluid oligoclonal bands in Chinese patients with multiple sclerosis: the prevalence and its association with clinical features
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1280020
- 3,510 views
- 5 citations